Mossakowski Medical Research Centre Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland.
University of Gdańsk - Medical University of Gdańsk, Intercollegiate Faculty of Biotechnology, Laboratory of Virus Molecular Biology, Poland.
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1312-1325. doi: 10.1016/j.bbadis.2017.03.002. Epub 2017 Mar 2.
Podocytes are dynamic polarized cells on the surface of glomerular capillaries and an essential component of the glomerular filtration barrier. Insulin increases the activation of protein kinase G type Iα (PKGIα) subunits, leading to podocyte dysfunction. In addition, accumulating evidence suggests that TRPC6 channels are crucial mediators of podocyte calcium handling and involved in the regulation of glomerular filtration. Therefore, we investigated whether TRPC6 is involved in the regulation of filtration barrier permeability by insulin via the PKGIα-dependent manner. TRPC channel inhibitor SKF96365 abolished insulin-dependent glomerular albumin permeability and transepithelial albumin flux in cultured rat podocytes. Insulin-evoked albumin permeability across podocyte monolayers was also blocked using TRPC6 siRNA. The effect of insulin on albumin permeability was mimicked by treating podocytes with TRPC channel activator (oleolyl-2-acetyl-sn-glycerol, OAG). Insulin or OAG treatment rapidly increased the superoxide generation through activation of NADH oxidase. TRPC inhibitor SKF96365 or siRNA knockdown of TRPC6 attenuated insulin-dependent increase of ROS production. Furthermore, TRPC inhibitor or downregulation of TRPC6 blocked insulin-induced rearrangement of the actin cytoskeleton and attenuated oxidative activation of PKGIα and changes in the phosphorylation of PKG target proteins MYPT1 and MLC. Moreover insulin regulated the PKGIα interaction with TRPC6 in cultured rat podocytes. Taken together, our data suggest a key role of TRPC6 channels in the mediation of insulin-dependent activation of PKGIα signaling pathways. Overall, we have identified a potentially important mechanism that may explain disturbances in filtration barrier permeability in many diseases with increased expression of TRPC6 and chronic Ca overload.
足细胞是肾小球毛细血管表面的具有极性的活跃细胞,也是肾小球滤过屏障的重要组成部分。胰岛素可增加蛋白激酶 G 型 Iα(PKGIα)亚基的激活,导致足细胞功能障碍。此外,越来越多的证据表明,TRPC6 通道是足细胞钙处理的关键介质,参与肾小球滤过的调节。因此,我们研究了胰岛素是否通过 PKGIα依赖性途径通过 TRPC6 调节滤过屏障通透性。TRPC 通道抑制剂 SKF96365 可消除胰岛素依赖性培养的大鼠足细胞肾小球白蛋白通透性和跨上皮白蛋白通量。使用 TRPC6 siRNA 也可阻断胰岛素诱导的足细胞单层白蛋白通透性。用 TRPC 通道激活剂(油酰基-2-乙酰基-sn-甘油,OAG)处理足细胞可模拟胰岛素对白蛋白通透性的作用。胰岛素或 OAG 处理可通过激活 NADH 氧化酶迅速增加超氧化物的产生。TRPC 抑制剂 SKF96365 或 TRPC6 的 siRNA 敲低可减弱胰岛素依赖性 ROS 产生的增加。此外,TRPC 抑制剂或 TRPC6 的下调可阻断胰岛素诱导的肌动球蛋白细胞骨架重排,并减弱 PKGIα 的氧化激活和 PKG 靶蛋白 MYPT1 和 MLC 磷酸化的变化。此外,胰岛素调节了培养的大鼠足细胞中 PKGIα 与 TRPC6 的相互作用。综上所述,我们的数据表明 TRPC6 通道在介导胰岛素依赖性 PKGIα 信号通路激活中起关键作用。总的来说,我们已经确定了一种潜在的重要机制,该机制可能解释了许多疾病中滤过屏障通透性的改变,这些疾病中 TRPC6 的表达增加和慢性钙超负荷。